FDA budget
This article was originally published in The Gray Sheet
Executive Summary
Both the Senate and House Appropriations Committees clear FDA fiscal 2008 funding bills July 19. The Senate bill includes $243.3 million for the device center, about $3 million more than the president requested in February (1"The Gray Sheet" Feb. 12, 2007, p. 3). The House matched the administration's request with a $240.1 million appropriation to CDRH. The Senate committee approved total FDA appropriations of $1.76 billion, slightly more than the House's $1.69 billion. Agency spending will also likely include about $48.5 million in device user fees, though user fee reauthorization legislation is still awaiting the outcome of a House-Senate conference (2"The Gray Sheet" July 16, 2007, p. 4). The House appropriations bill includes language preventing FDA from allowing individuals with financial conflicts to participate in advisory panel meetings. The provision has been included in funding bills for the past two years but has always been removed or weakened before final passage...
You may also be interested in...
FDA User Fee Reauthorization Passes House, Awaits Conference
The House passed broad-based FDA legislation July 11 that includes a package to reauthorize the medical device user fee program
GeneSearch Lymph Node Test Gets Nod For Breast Cancer Assessment
A molecular assay that helps evaluate the extent cancer might have spread from a breast tumor was recommended for approval by FDA's Immunology Devices Panel Nov. 16
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.